Estrogen is neuroprotective against hypoglycemic injury in murine N38 hypothalamic cells

Chakraborty,Tandra R.; Cohen,Joshua; Yohanan,Darien; Alicea,Eilliut; Weeks,Benjamin S.; Chakraborty,Sanjoy

doi:10.3892/mmr.2016.5952

Estrogen is neuroprotective against hypoglycemic injury in murine N38 hypothalamic cells

Authors:
- Tandra R. Chakraborty
- Joshua Cohen
- Darien Yohanan
- Eilliut Alicea
- Benjamin S. Weeks
- Sanjoy Chakraborty
View Affiliations

Affiliations: Department of Biology, Adelphi University, Garden City, NY 11530, USA, Department of Biological Sciences, New York City College of Technology, City University of New York, New York, NY 11201, USA
Published online on: November 18, 2016 https://doi.org/10.3892/mmr.2016.5952
Pages: 5677-5684

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Estrogen (E2) has been demonstrated to possess protective effects from hypoglycemic toxicity, particularly in the pancreas. In the central nervous system, several brain regions, such as the hypothalamus, are highly vulnerable to hypoglycemic injuries that may lead to seizures, coma, and mortality. The present study performed a novel in vitro assay of hypoglycemic injury to hypothalamic cells, and is the first study, to the best of our knowledge, to demonstrate that E2 protects hypothalamic cells from hypoglycemic toxicity. The toxic effects of hypoglycemia on hypothalamic cells in vitro was determined by performing cell counts, together with MTT and lactate dehydrogenase assays, using the N38 murine hypothalamic cell line. Following 24 and 48 h in hypoglycemic conditions, a 60 and 75% reduction in cell number and mitochondrial function was observed, which reached 80 and ~100% by 72 and 96 h, respectively. E2 treatment prevented the hypoglycemia‑induced loss in cell number and mitochondrial toxicity at 24 and 48 h. However at 72 and 96 h of hypoglycemic conditions, the neuroprotective effects of E2 on cell number or mitochondrial function was not significant or not present at all. In order to determine whether E2 exerted its effects through the AKT signaling pathway, the expression of proline‑rich AKT substrate of 40 kDa (PRAS40) was analyzed. No alterations in PRAS40 expression were observed when N38 cells were exposed to hypoglycemic shock. From the biochemical and molecular data obtained, the authors speculated that E2 exhibits neuroprotective effects against hypoglycemic shock in hypothalamic cells, which dissipates with time. Despite demonstrating no significant effect on total AKT/PRS40 activity, it is possible that E2 may mediate these neuroprotective effects by upregulating the phosphorylated‑AKT/pPRAS40 signaling pathway. The present study presented, to the best of our knowledge, the first in vitro model for hypoglycemic toxicity to hypothalamic cells, and provided evidence to suggest that E2 may protect hypothalamic cells from the damaging effects of hypoglycemia.

View Figures

View References

1	McCall AL: Cerebral glucose metabolism in diabetes mellitus. Eur J Pharmacol. 490:147–158. 2004. View Article : Google Scholar : PubMed/NCBI
2	Mooradian AD, Chung HC and Shah GN: GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol Aging. 18:469–474. 1997. View Article : Google Scholar : PubMed/NCBI
3	Hernández-Fonseca K, Massieu L, de la Cadena García S, Guzmán C and Camacho-Arroyo I: Neuroprotective role of estradiol against neuronal death induced by glucose deprivation in cultured rat hippocampal neurons. Neuroendocrinology. 96:41–50. 2012. View Article : Google Scholar : PubMed/NCBI
4	Routh VH, Hao L, Santiago AM, Sheng Z and Zhou C: Hypothalamic glucose sensing: Making ends meet. Front Syst Neurosci. 8:2362014. View Article : Google Scholar : PubMed/NCBI
5	Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ and Holsboer F: Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol Pharmacol. 51:535–541. 1997.PubMed/NCBI
6	Belcredito S, Vegeto E, Brusadelli A, Ghisletti S, Mussi P, Ciana P and Maggi A: Estrogen neuroprotection: The involvement of the Bcl-2 binding protein BNIP2. Brain Res Brain Res Rev. 37:335–342. 2001. View Article : Google Scholar : PubMed/NCBI
7	Cheng H, Isoda F and Mobbs CV: Estradiol impairs hypothalamic molecular responses to hypoglycemia. Brain Res. 1280:77–83. 2009. View Article : Google Scholar : PubMed/NCBI
8	Wise PM, Dubal DB, Wilson ME, Rau SW and Böttner M: Minireview: Neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology. 142:969–973. 2001. View Article : Google Scholar : PubMed/NCBI
9	Singh M, Meyer EM, Millard WJ and Simpkins JW: Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 644:305–312. 1994. View Article : Google Scholar : PubMed/NCBI
10	De Nicola AF, Pietranera L, Bellini MJ, Goya R, Brocca ME and Garcia-Segura LM: Protective effect of estrogens on the brain of rats with essential and endocrine hypertension. Horm Mol Biol Clin Investig. 4:549–557. 2010.PubMed/NCBI
11	Sandoval DA, Ertl AC, Richardson MA, Tate DB and Davis SN: Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia. Diabetes. 52:1749–1755. 2003. View Article : Google Scholar : PubMed/NCBI
12	Cardona-Gómez GP, Mendez P, DonCarlos LL, Azcoitia I and Garcia-Segura LM: Interactions of estrogens and insulin-like growth factor-I in the brain: Implications for neuroprotection. Brain Res Brain Res Rev. 37:320–334. 2001. View Article : Google Scholar : PubMed/NCBI
13	Singh M, Dykens JA and Simpkins JW: Novel mechanisms for estrogen-induced neuroprotection. Exp Biol Med (Maywood). 231:514–521. 2006.PubMed/NCBI
14	Goodman RL: Neural systems mediating the negative feedback actions of estradiol and progesterone in the ewe. Acta Neurobiol Exp (Wars). 56:727–741. 1996.PubMed/NCBI
15	Green PS, Gridley KE and Simpkins JW: Estradiol protects against beta-amyloid (25–35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett. 218:165–168. 1996. View Article : Google Scholar : PubMed/NCBI
16	Meda C, Vegeto E, Pollio G, Ciana P, Patrone C, Pellicciari C and Maggi A: Oestrogen prevention of neural cell death correlates with decreased expression of mRNA for the pro-apoptotic protein nip-2. J Neuroendocrinol. 12:1051–1059. 2000. View Article : Google Scholar : PubMed/NCBI
17	Gazzaley AH, Siegel SJ, Kordower JH, Mufson EJ and Morrison JH: Circuit-specific alterations of N-methyl-D-aspartate receptor subunit 1 in the dentate gyrus of aged monkeys. Proc Natl Acad Sci USA. 93:3121–3125. 1996. View Article : Google Scholar : PubMed/NCBI
18	Toran-Allerand CD: Mechanisms of estrogen action during neural development: Mediation by interactions with the neurotrophins and their receptors? J Steroid Biochem Mol Biol. 56:169–178. 1996. View Article : Google Scholar : PubMed/NCBI
19	Bishop J and Simpkins JW: Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol Cell Neurosci. 5:303–308. 1994. View Article : Google Scholar : PubMed/NCBI
20	Regan RF and Guo Y: Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia and excitatory amino acids in murine cortical cultures. Brain Res. 764:133–140. 1997. View Article : Google Scholar : PubMed/NCBI
21	Enmark E and Gustafsson JA: Oestrogen receptors-an overview. J Intern Med. 246:133–138. 1999. View Article : Google Scholar : PubMed/NCBI
22	Zhao L and Brinton RD: Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res. 1172:48–59. 2007. View Article : Google Scholar : PubMed/NCBI
23	Gu Q and Moss RL: 17 beta-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J Neurosci. 16:3620–3629. 1996.PubMed/NCBI
24	Watters JJ and Dorsa DM: Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms. J Neurosci. 18:6672–6680. 1998.PubMed/NCBI
25	Anderson GM and Barrell GK: Effects of thyroidectomy and thyroxine replacement on seasonal reproduction in the red deer hind. J Reprod Fertil. 113:239–250. 1998. View Article : Google Scholar : PubMed/NCBI
26	Razandi M, Pedram A, Greene GL and Levin ER: Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERalpha and Ebeta expressed in chinese hamster ovary cells. Mol Endocrinol. 13:307–319. 1999. View Article : Google Scholar : PubMed/NCBI
27	Rameh LE and Cantley LC: The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem. 274:8347–8350. 1999. View Article : Google Scholar : PubMed/NCBI
28	Datta SR, Brunet A and Greenberg ME: Cellular survival: A play in three Akts. Genes Dev. 13:2905–2927. 1999. View Article : Google Scholar : PubMed/NCBI
29	Buckmaster PS and Dudek FE: Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J Comp Neurol. 385:385–404. 1997. View Article : Google Scholar : PubMed/NCBI
30	Kovacina KS, Park GY, Bae SS, Guzzetta AW, Schaefer E, Birnbaum MJ and Roth RA: Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J Biol Chem. 278:10189–10194. 2003. View Article : Google Scholar : PubMed/NCBI
31	Wiza C, Nascimento EB and Ouwens DM: Role of PRAS40 in Akt and mTOR signaling in health and disease. Am J Physiol Endocrinol Metab. 302:E1453–E1460. 2012. View Article : Google Scholar : PubMed/NCBI
32	Zhang J, Zhang B, Yin Z, Chen F, Liu T, Xu H, Liu Y and Zhou X: Effects of metformin on the estrogen-induced proliferation and the expression of ER in human endometrial cancer cells. Zhonghua Fu Chan Ke Za Zhi. 49:932–937. 2014.(In Chinese). PubMed/NCBI
33	Welshons WV, Wolf MF, Murphy CS and Jordan VC: Estrogenic activity of phenol red. Mol Cell Endocrinol. 57:169–178. 1988. View Article : Google Scholar : PubMed/NCBI
34	Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
35	Regan RF and Panter SS: Traumatic neuronal injury in cortical cell culture is attenuated by 21-aminosteroids. Brain Res. 682:144–150. 1995. View Article : Google Scholar : PubMed/NCBI
36	Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E and Maggi A: Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol Endocrinol. 8:910–918. 1994. View Article : Google Scholar : PubMed/NCBI
37	Gazzaley AH, Benson DL, Huntley GW and Morrison JH: Differential subcellular regulation of NMDAR1 protein and mRNA in dendrites of dentate gyrus granule cells after perforant path transection. J Neurosci. 17:2006–2017. 1996.
38	Dykens JA: Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: Implications for neurodegeneration. J Neurochem. 63:584–591. 1994. View Article : Google Scholar : PubMed/NCBI
39	Kroemer G and Reed JC: Mitochondrial control of cell death. Nat Med. 6:513–519. 2000. View Article : Google Scholar : PubMed/NCBI
40	Simpkins JW and Dykens JA: Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev. 57:421–430. 2008. View Article : Google Scholar : PubMed/NCBI
41	Gruetter R: Glycogen: The forgotten cerebral energy store. J Neurosci Res. 74:179–183. 2003. View Article : Google Scholar : PubMed/NCBI
42	Tamrakar P and Briski KP: Estradiol regulation of hypothalamic astrocyte adenosine 5′-monophosphate-activated protein kinase activity: Role of hindbrain catecholamine signaling. Brain Res Bull. 110:47–53. 2015. View Article : Google Scholar : PubMed/NCBI
43	Vegeto E, Pollio G, Pellicciari C and Maggi A: Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF-alpha-induced apoptosis. FASEB J. 13:793–803. 1999.PubMed/NCBI
44	Billig H, Furuta I and Hsueh AJ: Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology. 133:2204–2212. 1993. View Article : Google Scholar : PubMed/NCBI
45	Behl C, Widmann M, Trapp T and Holsboer F: 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun. 216:473–482. 1995. View Article : Google Scholar : PubMed/NCBI
46	Clodfelder-Miller B, De Sarno P, Zmijewska AA, Song L and Jope RS: Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3. J Biol Chem. 280:39723–39731. 2005. View Article : Google Scholar : PubMed/NCBI
47	Lemmon MA and Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010. View Article : Google Scholar : PubMed/NCBI
48	Filardo EJ, Quinn JA, Bland KI and Frackelton AR Jr: Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 14:1649–1660. 2000. View Article : Google Scholar : PubMed/NCBI
49	Lazennec G, Thomas JA and Katzenellenbogen BS: Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators. J Steroid Biochem Mol Biol. 77:193–203. 2001. View Article : Google Scholar : PubMed/NCBI
50	Du B, Ohmichi M, Takahashi K, Kawagoe J, Ohshima C, Igarashi H, Mori-Abe A, Saitoh M, Ohta T, Ohishi A, et al: Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade. J Endocrinol. 183:605–615. 2004. View Article : Google Scholar : PubMed/NCBI
51	Kato H, Araki T, Murase K and Kogure K: Induction of tolerance to ischemia: Alterations in second-messenger systems in the gerbil hippocampus. Brain Res Bull. 29:559–565. 1992. View Article : Google Scholar : PubMed/NCBI
52	Zhao H, Sapolsky RM and Steinberg GK: Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol. 34:249–270. 2006. View Article : Google Scholar : PubMed/NCBI
53	Gervitz LM, Nalbant D, Williams SC and Fowler JC: Adenosine-mediated activation of Akt/protein kinase B in the rat hippocampus in vitro and in vivo. Neurosci Lett. 328:175–179. 2002. View Article : Google Scholar : PubMed/NCBI
54	Song G, Ouyang G and Bao S: The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 9:59–71. 2005. View Article : Google Scholar : PubMed/NCBI